CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Gastrointestinal Cancers » Colorectal Cancer

 

MR beats CT, ultrasound in staging advanced rectal cancer

C. P. Kaiser
March 7, 2003

MR is superior to CT and ultrasound for predicting local tumor invasion in patients with advanced rectal carcinoma, according to German researchers. They suggest that MR may replace CT as the primary staging modality.

Preoperative staging of advanced rectal tumors is important because most tumors that don't infiltrate the tunica muscularis can be operated on immediately, said lead researcher Dr. Jens C. Stollfuss of Munich, Germany.

"The presence or absence of muscularis involvement and the presence of positive nodes are the major determinants of local recurrence, and thus of the long-term survival of the patient," he said.

Stollfuss and colleagues evaluated 103 patients with tumors equal to or greater than T3 stage at initial presentation. MR's accuracy in predicting local tumor invasion was significantly higher than that of CT and ultrasound. Sensitivity and specificity for detecting mesorectal invasion were 84% and 68% for MR, 69% and 55% for CT, and 71% and 28% for ultrasound, respectively.

A separate comparison between T1- and T2-weighted MR images found no significant differences. Stollfuss suggested that it might not be necessary to give gadolinium to this patient population.

Responding to a question, Stollfuss said that multidetector CT may produce higher sensitivity than MR but will not improve specificity.

In another study, researchers from the Netherlands rated ultrasound's accuracy in assessing rectal cancer higher than that of MR and CT. However, an audience member pressed lead investigator Dr. Shandra Bipat to explain these findings, which are not in line with general experience. Bipat acknowledged that her research may have overestimated ultrasound because more ultrasound studies were included.

Bipat and colleagues reviewed the literature from 1985 to 2001 and found better sensitivity and specificity for endoluminal ultrasonography in assessing local rectal invasion, compared with CT and MR. Ultrasound's detection of lymph node involvement was comparable to CT and MR.

The selected literature had to fulfill the following criteria: minimal sample size of 20 patients, histopathology as a reference standard, sufficient data available to construct 2 x 2 tables, and original data.

Of 147 identified articles, 85 fulfilled all inclusion criteria. The summary estimates of sensitivity and specificity for endoluminal ultrasound in assessing local invasion were:

? 97% and 78% for T2 stage
? 93% and 81% for T3 stage
? 85% and 99% for T4 stage

CT and MRI each had lower values.

Summary sensitivity for lymph node involvement was between 59% and 69%; specificity was between 75% and 80%.

Although ultrasound received high marks, it has major limitations, Bipat said. It is suitable only for tumors within 10 cm of the anal canal, and is unsuitable for assessing stenotic tumors or detecting distant lymph nodes.

Data on helical CT are limited, she said, and these studies may increase CT's sensitivity and specificity. Additionally, new developments in MR might improve its numbers.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Axitinib Fails to Improve Survival in Metastatic Colorectal Cancer
May 6, 2013
A 47-Year-Old Patient With Chronic Abdominal Pain
April 26, 2013
Endometrial Cancer at Young Age Ups Risk for Colorectal Cancer
April 22, 2013
Smoking Linked to Poorer Prognosis in Colon Cancer
April 13, 2013
Colorectal Lesions
March 8, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SEARCH MEDICA SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Colorectal Cancer
Evidence on Colorectal Cancer
Guidelines on Colorectal Cancer
Patient Education on Colorectal Cancer
Clinical Trials on Colorectal Cancer
Practical Articles on Colorectal Cancer
Research and Reviews on Colorectal Cancer
All "Colorectal Cancer" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy